What is the current annual cash & cash equivalents of BSX?

As of today, BSX annual cash & cash equivalents is $2.05B

What is 1-year change in BSX annual cash & cash equivalents?

BSX annual cash & cash equivalents is up +289.52% year-over-year

What is 3-year change in BSX annual cash & cash equivalents?

BSX annual cash & cash equivalents is up +89.88% over the past 3 years

How far is BSX annual cash & cash equivalents from its all-time high?

BSX annual cash & cash equivalents is currently -3.22% below its historical high of $2.11B set on December 31, 2021

How does BSX annual cash & cash equivalents rank versus sector peers?

BSX annual cash & cash equivalents is higher than 95.33% of companies in Healthcare sector

When is BSX next annual earnings release?

As of today, the next annual earnings release for BSX has not been scheduled

What is the current quarterly cash & cash equivalents of BSX?

As of today, BSX quarterly cash & cash equivalents is $648.00M

What is BSX quarterly cash & cash equivalents most recent change?

BSX quarterly cash & cash equivalents was down -57.48% on June 30, 2026

What is 1-year change in BSX quarterly cash & cash equivalents?

BSX quarterly cash & cash equivalents is up +0.78% year-over-year

How far is BSX quarterly cash & cash equivalents from its all-time high?

BSX quarterly cash & cash equivalents is currently -78.31% below its historical high of $2.99B set on June 30, 2024

How does BSX quarterly cash & cash equivalents rank versus sector peers?

BSX quarterly cash & cash equivalents is higher than 88.16% of companies in Healthcare sector

When is BSX next earnings release?

The next earnings release for BSX is on October 28, 2026

BSX Cash & Equivalents History & Chart Since 1991

Annual Cash & Cash Equivalents

$2.05B$1.52B+289.52%

December 31, 2025

Summary

Current Value: As of today, BSX annual cash & cash equivalents is $2.05B, up +289.52% on December 31, 2025
Historical Performance: BSX annual cash & cash equivalents is up +89.88% over the past 3 years, up +5.30% over the past 5 years
All-Time High Comparison: BSX annual cash & cash equivalents is currently -3.22% below its historical high of $2.11B set on December 31, 2021
3-Year Low Comparison: BSX annual cash & cash equivalents is +289.52% above its 3-year low of $525.00M reached on December 31, 2024
Sector Comparison: BSX annual cash & cash equivalents is higher than 95.33% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

BSX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$2.05B	+289.5%	+89.9%	+5.3%	+860.1%
Quarterly Cash & Cash Equivalents	Jun 30, 26	$648.00M	+0.8%	+15.5%	-77.2%	+320.8%
Price	Aug 14, 26	$51.83	-50.2%	+1.0%	+16.9%	+708.6%
Annual Current Assets	Dec 31, 25	$8.79B	+27.1%	+52.7%	+31.4%	+143.3%
Annual Total Liabilities	Dec 31, 25	$19.20B	+10.4%	+28.9%	+24.3%	+77.3%
Annual Working Capital	Dec 31, 25	$3.36B	+544.0%	+71.4%	+11.3%	+233.5%
Annual Net Income	Dec 31, 25	$2.89B	+56.7%	+314.3%	+3626.8%	+371.6%

Cash and Cash Equivalents Highs

BSX Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$2.05B	Dec 31, 25	at high
5Y	$2.11B	Dec 31, 21	-3.2%
All	$2.11B	Dec 31, 21	-3.2%

Cash and Cash Equivalents Lows

BSX Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$525.00M	Dec 31, 24	+289.5%
5Y	$525.00M	Dec 31, 24	+289.5%
All	$5.90M	Dec 31, 91	>+9999.0%

Cash and Cash Equivalents History

Year	Value	Change
2025	$2.05B	+289.5%
2024	$525.00M	-47.2%
2023	$995.00M	-7.6%
2022	$1.08B	-49.0%
2021	$2.11B	+8.8%
2020	$1.94B	+244.9%
2019	$563.00M	-29.7%
2018	$801.00M	-19.2%
2017	$991.00M	+125.7%
2016	$439.00M	+37.6%
2015	$319.00M	-45.7%
2014	$587.00M	+170.5%
2013	$217.00M	+4.8%
2012	$207.00M	-22.5%
2011	$267.00M	+25.4%
2010	$213.00M	-75.3%
2009	$864.00M	-47.3%
2008	$1.64B	+13.0%

Year	Value	Change
2007	$1.45B	-12.9%
2006	$1.67B	+96.7%
2005	$848.00M	-48.3%
2004	$1.64B	+118.1%
2003	$752.00M	+171.5%
2002	$277.00M	+53.9%
2001	$180.00M	+200.0%
2000	$60.00M	-23.1%
1999	$78.00M	+3.4%
1998	$75.40M	-6.1%
1997	$80.31M	-0.3%
1996	$80.55M	-46.6%
1995	$150.77M	+27.4%
1994	$118.36M	+14.9%
1993	$103.03M	-24.9%
1992	$137.17M	+2,224.9%
1991	$5.90M	-

FAQ

What is the current annual cash & cash equivalents of BSX?: As of today, BSX annual cash & cash equivalents is $2.05B
What is 1-year change in BSX annual cash & cash equivalents?: BSX annual cash & cash equivalents is up +289.52% year-over-year
What is 3-year change in BSX annual cash & cash equivalents?: BSX annual cash & cash equivalents is up +89.88% over the past 3 years
How far is BSX annual cash & cash equivalents from its all-time high?: BSX annual cash & cash equivalents is currently -3.22% below its historical high of $2.11B set on December 31, 2021
How does BSX annual cash & cash equivalents rank versus sector peers?: BSX annual cash & cash equivalents is higher than 95.33% of companies in Healthcare sector
When is BSX next annual earnings release?: As of today, the next annual earnings release for BSX has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$648.00M$876.00M-57.48%

June 30, 2026

Summary

Current Value: As of today, BSX quarterly cash & cash equivalents is $648.00M, down -57.48% on June 30, 2026
Historical Performance: BSX quarterly cash & cash equivalents is up +0.78% year-over-year, up +15.51% over the past 3 years
All-Time High Comparison: BSX quarterly cash & cash equivalents is currently -78.31% below its historical high of $2.99B set on June 30, 2024
3-Year Low Comparison: BSX quarterly cash & cash equivalents is +23.43% above its 3-year low of $525.00M reached on December 31, 2024
Sector Comparison: BSX quarterly cash & cash equivalents is higher than 88.16% of companies in Healthcare sector

Performance

BSX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Jun 30, 26	$648.00M	-57.5%	+0.8%	+15.5%	-77.2%
Annual Cash & Cash Equivalents	Dec 31, 25	$2.05B	–	+289.5%	+89.9%	+5.3%
Price	Aug 14, 26	$51.83	-3.2%	-50.2%	+1.0%	+16.9%
Quarterly Current Assets	Jun 30, 26	$7.97B	-8.2%	+11.9%	+35.4%	+18.0%
Quarterly Total Liabilities	Jun 30, 26	$20.04B	+9.8%	+6.0%	+32.6%	+31.6%
Quarterly Working Capital	Jun 30, 26	$1.54B	-62.5%	-20.0%	+16.6%	-42.5%
Quarterly Net Income	Jun 30, 26	$905.00M	-32.4%	+13.8%	+235.2%	+386.6%

Quarterly Cash & Cash Equivalents Highs

BSX Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$2.05B	Dec 31, 25	-68.3%
3Y	$2.99B	Jun 30, 24	-78.3%
5Y	$2.99B	Jun 30, 24	-78.3%
All	$2.99B	Jun 30, 24	-78.3%

Quarterly Cash & Cash Equivalents Lows

BSX Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$643.00M	N/A	+0.8%
3Y	$525.00M	Dec 31, 24	+23.4%
5Y	$408.00M	Jun 30, 22	+58.8%
All	$5.90M	Dec 31, 91	>+9999.0%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Jun 2026	$648.00M	-57.5%
Mar 2026	$1.52B	-25.5%
Dec 2025	$2.05B	+48.9%
Sep 2025	$1.37B	+113.5%
Jun 2025	$643.00M	-22.3%
Mar 2025	$828.00M	+57.7%
Dec 2024	$525.00M	-79.6%
Sep 2024	$2.57B	-13.9%
Jun 2024	$2.99B	+23.4%
Mar 2024	$2.42B	+143.4%
Dec 2023	$995.00M	-7.4%
Sep 2023	$1.08B	+91.6%
Jun 2023	$561.00M	-20.4%
Mar 2023	$705.00M	-34.5%
Dec 2022	$1.08B	+139.3%
Sep 2022	$450.00M	+10.3%
Jun 2022	$408.00M	-13.4%
Mar 2022	$471.00M	-77.7%
Dec 2021	$2.11B	+0.5%
Sep 2021	$2.10B	-26.0%
Jun 2021	$2.84B	+29.2%
Mar 2021	$2.20B	+13.3%
Dec 2020	$1.94B	-13.1%
Sep 2020	$2.24B	+13.6%
Jun 2020	$1.97B	+199.2%
Mar 2020	$658.00M	+16.9%
Dec 2019	$563.00M	-11.2%
Sep 2019	$634.00M	-77.2%
Jun 2019	$2.78B	-2.9%
Mar 2019	$2.86B	+257.4%
Dec 2018	$801.00M	-15.6%
Sep 2018	$949.00M	-4.6%
Jun 2018	$995.00M	-12.5%
Mar 2018	$1.14B	+14.7%
Dec 2017	$991.00M	+50.4%
Sep 2017	$659.00M	+47.8%
Jun 2017	$446.00M	+57.6%
Mar 2017	$283.00M	-35.5%
Dec 2016	$439.00M	+85.2%
Sep 2016	$237.00M	-45.9%
Jun 2016	$438.00M	+29.6%
Mar 2016	$338.00M	+6.0%
Dec 2015	$319.00M	-8.9%
Sep 2015	$350.00M	-61.2%
Jun 2015	$903.00M	+273.1%
Mar 2015	$242.00M	-58.8%
Dec 2014	$587.00M	+138.6%
Sep 2014	$246.00M	-31.1%
Jun 2014	$357.00M	+86.9%
Mar 2014	$191.00M	-12.0%
Dec 2013	$217.00M	-62.0%
Sep 2013	$571.00M	+7.7%
Jun 2013	$530.00M	+97.8%
Mar 2013	$268.00M	+29.5%
Dec 2012	$207.00M	-41.2%
Sep 2012	$352.00M	-5.1%
Jun 2012	$371.00M	+30.6%
Mar 2012	$284.00M	+6.4%
Dec 2011	$267.00M	-3.3%
Sep 2011	$276.00M	+79.2%
Jun 2011	$154.00M	-74.1%
Mar 2011	$595.00M	+179.3%
Dec 2010	$213.00M	-65.9%
Sep 2010	$624.00M	-23.1%
Jun 2010	$811.00M	+56.3%
Mar 2010	$519.00M	-39.9%
Dec 2009	$864.00M	-37.4%

Month	Value	Change
Sep 2009	$1.38B	+15.7%
Jun 2009	$1.19B	+33.1%
Mar 2009	$897.00M	-45.3%
Dec 2008	$1.64B	-5.4%
Sep 2008	$1.73B	+7.3%
Jun 2008	$1.62B	-7.1%
Mar 2008	$1.74B	+19.8%
Dec 2007	$1.45B	+17.4%
Sep 2007	$1.24B	-18.3%
Jun 2007	$1.51B	+13.0%
Mar 2007	$1.34B	-19.7%
Dec 2006	$1.67B	+8.2%
Sep 2006	$1.54B	+33.2%
Jun 2006	$1.16B	+6.8%
Mar 2006	$1.08B	+27.7%
Dec 2005	$848.00M	-7.5%
Sep 2005	$917.00M	+3.9%
Jun 2005	$883.00M	-7.6%
Mar 2005	$956.00M	-41.7%
Dec 2004	$1.64B	+6.4%
Sep 2004	$1.54B	+22.1%
Jun 2004	$1.26B	+68.0%
Dec 2003	$752.00M	+40.0%
Sep 2003	$537.00M	+31.0%
Jun 2003	$410.00M	+39.5%
Mar 2003	$294.00M	+6.1%
Dec 2002	$277.00M	+6.9%
Sep 2002	$259.00M	+28.9%
Mar 2002	$201.00M	+11.7%
Dec 2001	$180.00M	+81.8%
Sep 2001	$99.00M	+19.3%
Jun 2001	$83.00M	-1.2%
Mar 2001	$84.00M	+40.0%
Dec 2000	$60.00M	+20.0%
Sep 2000	$50.00M	-35.9%
Dec 1999	$78.00M	+5.4%
Jun 1999	$74.00M	-35.1%
Mar 1999	$114.00M	+51.2%
Dec 1998	$75.40M	-62.4%
Sep 1998	$200.35M	+28.5%
Jun 1998	$155.92M	+0.9%
Mar 1998	$154.53M	+166.4%
Dec 1997	$58.00M	+6.8%
Sep 1997	$54.30M	+0.4%
Jun 1997	$54.10M	-24.4%
Mar 1997	$71.60M	-0.8%
Dec 1996	$72.20M	+21.5%
Sep 1996	$59.40M	+12.7%
Jun 1996	$52.70M	-49.4%
Mar 1996	$104.10M	-9.6%
Dec 1995	$115.10M	-25.7%
Sep 1995	$155.00M	-14.1%
Jun 1995	$180.50M	-5.6%
Mar 1995	$191.20M	+112.4%
Dec 1994	$90.00M	-5.6%
Sep 1994	$95.30M	+38.3%
Jun 1994	$68.90M	-2.4%
Mar 1994	$70.60M	+16.1%
Dec 1993	$60.80M	+24.8%
Sep 1993	$48.70M	-5.6%
Jun 1993	$51.60M	-50.2%
Mar 1993	$103.60M	+8.6%
Dec 1992	$95.40M	-26.5%
Sep 1992	$129.80M	+10.2%
Jun 1992	$117.80M	+1,254.0%
Mar 1992	$8.70M	+47.5%
Dec 1991	$5.90M	-

FAQ

What is the current quarterly cash & cash equivalents of BSX?: As of today, BSX quarterly cash & cash equivalents is $648.00M
What is BSX quarterly cash & cash equivalents most recent change?: BSX quarterly cash & cash equivalents was down -57.48% on June 30, 2026
What is 1-year change in BSX quarterly cash & cash equivalents?: BSX quarterly cash & cash equivalents is up +0.78% year-over-year
How far is BSX quarterly cash & cash equivalents from its all-time high?: BSX quarterly cash & cash equivalents is currently -78.31% below its historical high of $2.99B set on June 30, 2024
How does BSX quarterly cash & cash equivalents rank versus sector peers?: BSX quarterly cash & cash equivalents is higher than 88.16% of companies in Healthcare sector
When is BSX next earnings release?: The next earnings release for BSX is on October 28, 2026

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

BSX Official Website www.bostonscientific.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
BSX Profile on Yahoo Finance finance.yahoo.com/quote/BSX
BSX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bsx